Identification of antigenically active tryptic fragments of apical membrane antigen-1 (AMA1) of Plasmodium chabaudi malaria: Strategies for assembly of immunologically active peptides

Vaccine

Volumn 20, Issue 29-30, 2002, Pages 3477-3484

  Salvatore, Daniela ^a   Hodder, Anthony N ^b   Zeng, Weiguang ^a   Brown, Lorena E ^a   Anders, Robin F ^b   Jackson, David C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Malaria; Synthetic peptide; Synthetic vaccine

Indexed keywords

EPITOPE; HYPERIMMUNE GLOBULIN; IMMUNOLOGIC AGENT; MALARIA VACCINE; PARASITE ANTIGEN; PEPTIDE FRAGMENT; SYNTHETIC PEPTIDE; TRYPSIN;

AMINO TERMINAL SEQUENCE; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ANTIGEN BINDING; ANTIGENICITY; APICAL MEMBRANE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISULFIDE BOND; FEMALE; IMMUNOGENICITY; MALARIA; MOLECULE; MOUSE; NONHUMAN; OXIDATION; PARASITEMIA; PLASMODIUM CHABAUDI; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; STEREOCHEMISTRY; SUBSPECIES;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; DIMERIZATION; FEMALE; MALARIA VACCINES; MEMBRANE PROTEINS; MICE; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PLASMODIUM CHABAUDI; PROTOZOAN PROTEINS; TRYPSIN;

EID: 0037019883     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00347-X     Document Type: Article

References (26)

1. Howell S.A., Withers-Martinez C., Kocken C.H., Thomas A.W., Blackman M.J. Proteolytic processing and primary structure of Plasmodium falciparum apical membrane antigen-1. J. Biol. Chem. 276(33):2001;31311-31320.
2. Deans J.A., Knight A.M., Jean W.C., Waters A.P., Cohen S., Mitchell G.H. Vaccination trials in rhesus monkeys with a minor, invariant Plasmodium knowlesi 66 kDa merozoite antigen. Parasite Immunol. 10:1988;535-552.
3. Collins W.E., Pye D., Crewther P.E., Vandeberg K.L., Garland G.G., Sulzer A.J.et al. Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-1 of Plasmodium fragile. Am. J. Trop. Med. Hyg. 51:1994;711-719.
4. Crewther P.E., Matthew M.L., Flegg R.H., Anders R.F. Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes. Infect. Immun. 64(8):1996;3310-3317.
5. Anders R.F., Crewther P.E., Edwards S., Margetts M., Matthew M.L., Pollock B.et al. Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi. Vaccine. 16(2/3):1998;240-247.
6. Narum D.L., Ogun S.A., Thomas A.W., Holder A.A. Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM blood-stage infection. Infect. Immun. 68(5):2000;2899-2906.
7. Cheng Q., Saul A. Sequence analysis of the apical membrane antigen I (AMA-1) of Plasmodium vivax. Mol. Biochem. Parasitol. 65(1):1994;183-187.
8. Marshall V.M., Peterson M.G., Lew A.M., Kemp D.J. Structure of the apical membrane antigen I (AMA-1) of Plasmodium chabaudi. Mol. Biochem. Parasitol. 37(2):1989;281-283.
9. Waters A.P., Thomas A.W., Deans J.A., Mitchell G.H., Hudson D.E., Miller L.H.et al. A merozoite receptor protein from Plasmodium knowlesi is highly conserved and distributed throughout Plasmodium. J. Biol. Chem. 265(29):1990;17974-17979.
10. Hodder A.N., Crewther P.E., Matthew M.L., Reid G.E., Moritz R.L., Simpson R.J.et al. The disulfide bond structure of Plasmodium apical membrane antigen-1. J. Biol. Chem. 271(46):1996;29446-29452.
11. Hodder A.N., Crewther P.E., Anders R.F. Specificity of the protective antibody response to apical membrane antigen 1. Infect. Immun. 69(5):2001;3286-3294.
12. Wade J.D., Bedford J., Sheppard R.C., Tregear G.W. DBU as an N alpha-deprotecting reagent for the fluorenylmethoxycarbonyl group in continuous flow solid-phase peptide synthesis. Peptide Res. 4(3):1991;194-199.
13. Hancock W.S., Battersby J.E. A micro-test for the detection on incomplete coupling reactions in solid-phase peptide synthesis using 2,4,6-trinitrobenzene sulfonic acid. Anal. Biochem. 71:1976;260-264.
14. Brown L.E., Murray J.M., Anders E.M., Tang X., White D.O., Tregear G.W.et al. Genetic control and fine specificity of the immune response to a synthetic peptide of influenza virus hemagglutinin. J. Virol. 62(5):1988;1746-1752.
15. Ben-Yedidia T., Arnon R. Design of peptide and polypeptide vaccines. Curr. Opin. Biotech. 8:1997;442-448.
16. Berzofsky J.A. Antigenic peptide interaction with MHC molecules: implications for the design of artificial vaccines. Semin. Immunol. 3(4):1991;203-216.
17. Milich D.R. Synthetic peptides: prospects for vaccine development. Semin. Immunol. 2(5):1990;307-315.
18. Herzenberg L.A., Tokuhisa T. Carrier-priming leads to hapten-specific suppression. Nature. 285(5767):1980;664-667.
19. Schutze M.P., Leclerc C., Jolivet M., Audibert F., Chedid L. Carrier-induced epitopic suppression, a major issue for future synthetic vaccines. J. Immunol. 135(4):1985;2319-2322.
20. Briand J.P., Muller S., Van Regonmortel M.H.V. Synthetic peptides as antigens: pitfalls of conjugation methods. J. Immunol. Methods. 78:1985;59-69.
21. Uthaipibull C., Aufiero B., Syed S.E., Hansen B., Guevara Patino J.A., Angov E.et al. Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum. J. Mol. Biol. 307(5):2001;1381-1394.
22. Kocken C.H., Narum D.L., Massougbodji A., Ayivi B., Dubbeld M.A., van der Wel A.et al. Molecular characterisation of Plasmodium reichenowi apical membrane antigen-1 (AMA-1), comparison with P. falciparum AMA-1, and antibody-mediated inhibition of red cell invasion. Mol. Biochem. Parasitol. 109(2):2000;147-156.
23. Coley A.M., Campanale N.V., Casey J.L., Hodder A.N., Crewther P.E., Anders R.F.et al. Rapid and precise epitope mapping of monoclonal antibodies against Plasmodium falciparum AMA1 by combined phage display of fragments and random peptides. Protein Eng. 14(9):2001;691-698.
24. Jackson D.C., O'Brien-Simpson N.M., Ede N.J., Brown L.E. Free radical induced polymerization of synthetic peptides into polymeric immunogens. Vaccine. 15(15):1997;1697-1705.
25. O'Brien-Simpson N.M., Ede N.J., Brown L.E., Swan J., Jackson D.C. Polymerisation of unprotected synthetic peptides: a view towards synthetic peptide vaccines. J. Am. Chem. Soc. 119:1997;1183-1188.
26. Brandt E.R., Sriprakash K.S., Hobb R.I., Hayman W.A., Zeng W., Batzloff M.R.et al. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population. Nat. Med. 6(4):2000;455-459.